Gedatolisib Patent Expiration

Gedatolisib was first introduced by Celcuity Inc in its drug Revtorpyk on Jul 14, 2026.


Gedatolisib Patents

Given below is the list of patents protecting Gedatolisib, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Revtorpyk US12350276 Methods For The Treatment Of Cancer Using 1-(4-{[4-(Dimethylamino)Piperidin-1-Yl]Carbonyl}Phenyl)-3-[4-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)Phenyl]Urea Aug 31, 2042 Celcuity
Revtorpyk US12109308 Aqueous Formulation Comprising 1-(4-{[4-(Dimethylamino)Piperidin-1-Yljcarbonyl}Phenyl)-3-[4-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)Phenyl]Urea Jan 02, 2041 Celcuity
Revtorpyk US8039469 Triazine Compounds As Pi3 Kinase And Mtor Inhibitors Dec 17, 2029 Celcuity
Revtorpyk US8217036 Triazine Compounds As Pi3 Kinase And Mtor Inhibitors May 22, 2029 Celcuity
Revtorpyk US8575159 Triazine Compounds As Pi3 Kinase And Mtor Inhibitors May 22, 2029 Celcuity
Revtorpyk US8748421 Triazine Compounds As P13 Kinase And Mtor Inhibitors May 22, 2029 Celcuity
Revtorpyk US9174963 Triazine Compounds As Pi3 Kinase And Mtor Inhibitors May 22, 2029 Celcuity



Gedatolisib's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Gedatolisib Generic API Manufacturers

Given below is the list of companies who have filed for Gedatolisib generic, along with the locations of their manufacturing plants worldwide.